TIRZEPATIDE 30MG

Tirzepatide (30MG) is a synthetic peptide designed for laboratory investigation of dual incretin receptor
pathways. As a GIP and GLP-1 receptor agonist, this compound enables research into metabolic
signaling mechanisms, glucose homeostasis, and receptor binding dynamics. Supplied as lyophilized white powder at ≥99% purity (HPLC verified). Suitable for in vitro studies
investigating incretin pathway interactions and comparative peptide pharmacology. Store at -20°C
to -80°C sealed, or 2-8°C reconstituted for up to 28 days.

This product is sold strictly for research purposes. Not intended for human or animal use.
Not FDA-approved